EUVIMEDFaigh amach EUVIMED
CrossrefCárta eolais

Inter-Rater Agreement in PD-L1 (22C3) Expression Evaluation in Colon Cancer

Dea N.M. Jepsen, Marianne B. Jensen, Trine L. Grantzau, Astrid L.B. Bennedsen, Thomas T. Eriksen, Michael Bzorek, Ismail Gögenur, Anne-Marie K. Fiehn

Applied Immunohistochemistry & Molecular Morphology · 2026-11 · 34 (6) · 403-411

DOI: 10.1097/pai.0000000000001345 ↗
AchoimreSonraí leabharliosta

Achoimre

Programmed death-ligand 1 (PD-L1) is a predictive biomarker in various cancers. In colorectal cancer, PD-L1 expression evaluation is not part of the routine examination and standardized evaluation methods are lacking. This study aimed to examine inter-rater agreement in PD-L1 expression evaluation in patients with colon cancer (CC) using different manual scoring methods, and to compare the manual methods to a digital evaluation. Two pathologists evaluated 188 PD-L1-stained slides from patients with CC. The tumor proportion score (TPS) and immune cell score (ICS) were categorized as

Eolas a oireann do do chuid oibre.

Ó thús saor in aisce agus taighde litríochta pearsanta go dtí an Research Suite iomlán.

Féach ar na taraifí →

An bhfuil gach téacs iomlán ó fhoilsitheoirí san áireamh?

Ní hea. Is ábhair éagsúla iad tagairtí bibleagrafaíocha, achoimrí agus lánthéacsanna. Braitheann fáil an lánthéacs ar an bhfoinse, Open Access agus ar na ceadúnais atá agat cheana. Ní chuireann taraif EUVIMED cearta breise foilsitheora ina n-ionad.

Féach ar na taraifí →